Enterprise Value
789.2M
Cash
96.96M
Avg Qtr Burn
-6.009M
Short % of Float
11.69%
Insider Ownership
12.70%
Institutional Own.
81.34%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Jeuveau (prabotulinumtoxinA-xvfs) Details Glabellar lines , Benign tumor | Approved Quarterly sales | |
Jeuveau “Extra-Strength” Details Glabellar lines | Phase 2 Update |